In:
Hypertension, Ovid Technologies (Wolters Kluwer Health), Vol. 63, No. 6 ( 2014-06), p. 1345-1353
Abstract:
The male sex has a higher risk to develop coronary artery diseases, including atherosclerosis. The androgen receptor (AR) is expressed in several atherosclerosis-associated cell types, including monocytes/macrophages, endothelial cells (ECs), and smooth muscle cells (SMCs), but its pathophysiological role in each cell type during the development of atherosclerotic lesions remains unclear. Using the Cre-loxP system, we selectively knocked out AR in these 3 cell types and the resultant AR knockout (ARKO) mice, monocyte/macrophage ARKO, EC-ARKO, and SMC-ARKO, were then crossed with the low-density lipoprotein receptor (LDLR) deficient (LDLR −/− ) mice to develop monocyte/macrophage ARKO-LDLR −/− , EC-ARKO-LDLR −/− , and SMC-ARKO-LDLR −/− mice for the study of atherosclerosis. The results showed that the monocyte/macrophage ARKO-LDLR −/− mice had reduced atherosclerosis compared with the wild-type-LDLR −/− control mice. However, no significant difference was detected in EC-ARKO-LDLR −/− and SMC-ARKO-LDLR −/− mice compared with wild-type-LDLR −/− mice, suggesting that the AR in monocytes/macrophages, and not in ECs and SMCs, plays a major role to promote atherosclerosis. Molecular mechanism dissection suggested that AR in monocytes/macrophages upregulated the tumor necrosis factor-α, integrin β2, and lectin-type oxidized LDL receptor 1 molecules that are involved in 3 major inflammation-related processes in atherosclerosis, including monocytes/macrophages migration and adhesion to human umbilical vein ECs, and subsequent foam cell formation. Targeting AR via the AR degradation enhancer, ASC-J9, in wild-type-LDLR −/− mice showed similar effects as seen in monocyte/macrophage ARKO-LDLR −/− mice with little influence on lipid profile. In conclusion, the AR in monocytes/macrophages plays key roles in atherosclerosis and targeting AR with ASC-J9 may represent a new potential therapeutic approach to battle atherosclerosis.
Type of Medium:
Online Resource
ISSN:
0194-911X
,
1524-4563
DOI:
10.1161/HYPERTENSIONAHA.113.02804
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2014
detail.hit.zdb_id:
2094210-2
Permalink